Table 3.
Relative contribution (%) for studied chronic CSCR features in CNV development.
| Feature | Group I (55 patients) = not complicated N (%) |
Group II (5 patients) = complicated N (%) |
|---|---|---|
| RPED | 9 (0.32) | 0 (0.00) |
| IRPED | 41 (2.02) | 5 (0.66) |
| IRPED-T | 12 (0.16) | 0 (1.80) |
| IRPED-O | 29 (1.02) | 5 (11.22∗∗) |
| FATR | 11 (13.18∗∗) | 3 (75.00∗∗) |
| DOLR | 44 (3.03) | 5 (0.45) |
| CEXC | 1 (0.26) | 0 (0.45) |
| SRD | 35 (2.56) | 4 (0.00) |
| SRPED-EF | 30 (0.07) | 5 (0.45) |
| CT | 45 (1.23) | 5 (7.84∗∗) |
| Total relative contribution (%) | 11.10 | 65.6 |
∗∗Significant at 1%. CEXC: choroidal excavation; CT: choroidal thickness; DOLR: disrupted outer retinal layers; FT: foveal thinning; IRPED: irregular flat PED; IRPED-T: irregular flat PED with translucent (empty) sub-RPE space; IRPED-O: irregular flat PED with opaque (filled) sub-RPE space; RPED: regular smooth PED; SRD: subretinal deposits; SRPED-EF: sub-RPE deposits not related to irregular flat PED.